Wariness in Indonesia as Chinese Sinovac COVID-19 jabs start


  • World
  • Wednesday, 13 Jan 2021

FILE PHOTO: Officers carry COVID-19 vaccine amid the coronavirus disease (COVID-19) pandemic in Banda Aceh, Aceh Province, Indonesia, January 12, 2021. Ampelsa/Antara Foto via REUTERS

JAKARTA (Reuters) - Indonesian doctors have suffered one of the world's highest death rates from the coronavirus, but that has not stopped some from voicing concerns over the vaccination campaign.

Nearly 1.5 million health workers are first in line to be immunised in the world's fourth most populous country after it became the first outside China to start mass vaccinations with Chinese company Sinovac Biotech's CoronaVac.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

2 foreign tourists killed in road accident in Namibia
U.S. dollar ticks down
News Analysis: T�rkiye keeps key policy rate unchanged amid soaring inflation
Germany's Merck invests 300 mln euros in life science facility
5 Tanzanian crew members, Zanzibar registered cargo ship missing in Indian Ocean
Interview: Zimbabwe seeks to harness China's innovation experience for dndustrialization, says minister
DRC reports over 24,000 malaria-related deaths in 2023
Somalia cuts malaria prevalence to 4 pct in 2023, despite new strains: WHO
Roundup: IOM urges action to prevent migrant tragedies in the Red Sea
South Africa aims to eliminate malaria by 2028

Others Also Read